P-Cymene

P-Cymene

SCHEMBL186659

CC(C)c1ccc(C(Cl)(Cl)Cl)c(Cl)c1.Cc1ccc(C(C)C)cc1.[Ru].[Ru]

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ LMNA P02545 3/20 0.36
▸ BCHE P06276 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ PTGS1 P23219 2/20 0.35
▸ TRPA1 O75762 1/20 0.35
▸ CACNA1C Q13936 1/20 0.35
▸ HIF1A Q16665 2/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ SLC6A2 P23975 1/20 0.32
▸ SLC6A4 P31645 1/20 0.32
▸ SLC6A3 Q01959 1/20 0.32
▸ HTT P42858 3/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5380073 0.77 TDP1 (0.60) CYP3A4TSHRMAPK1TDP1LMNA
SCHEMBL19542869 0.76 LMNA (0.38) CYP3A4TSHRMAPK1TDP1LMNA
SCHEMBL9967733 0.74 PDE2A (0.43) LMNAHIF1ACYP2D6CYP2C9PDE2A
P-Cymene SCHEMBL4860410 0.74 ACHE (0.50) TDP1LMNABCHEACHEPTGS1
P-Cymene SCHEMBL29006180 0.74 ACHE (0.50) TDP1LMNABCHEACHEPTGS1
P-Cymene SCHEMBL3684076 0.74 ACHE (0.50) TDP1LMNABCHEACHEPTGS1
SCHEMBL1764670 0.74 TSHR (0.56) CYP3A4TSHRMAPK1TDP1LMNA
P-Cymene SCHEMBL2239767 0.72 LMNA (0.36) LMNABCHEACHEPTGS1TRPA1
P-Cymene SCHEMBL2570692 0.72 ACHE (0.47) TDP1LMNABCHEACHEPTGS1
P-Cymene SCHEMBL4005540 0.72 ACHE (0.47) TDP1LMNABCHEACHEPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2868659-B1 Method for producing optically active naphthalene compound MITSUBISHI TANABE PHARMA CORP (JP) 2016-05-04 — — EP claimed
US-9181217-B2 Method for producing optically active naphthalene compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2015-11-10 — — US claimed
US-20150152082-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2015-06-04 — — US claimed
EP-2868659-A1 Method for producing optically active naphthalene compound Mitsubishi Tanabe Pharma Corporation (JP) 2015-05-06 — — EP claimed
EP-2749558-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2014-07-02 — — EP claimed
US-20130237708-A1 Optically Active Cyclic Alcohol Compound And Method For Preparing The Same MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-09-12 — — US claimed
EP-1944291-B1 Optically active cyclic alcohol compound and method for producing same MITSUBISHI TANABE PHARMA CORP (JP) 2012-06-13 — — EP claimed
US-20100152451-A1 OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-17 — — US claimed
EP-1944291-A1 OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PRODUCING SAME Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-16 — — EP claimed
US-20230416173-A1 Distillation Process and Apparatus with Pressure Corrected Temperature Heat Source Control INEOS ACETYLS UK LIMITED (GB) 2023-12-28 — — US disclosed
US-20230415065-A1 Processes and Apparatuses for Distillation of an Acetic Acid and Propionic Acid-Containing Stream in an Acetic Acid Production Unit INEOS ACETYLS UK LIMITED (GB) 2023-12-28 — — US disclosed
US-20230338888-A1 Processes for Treating Off-Gas In An Acetic Acid Production Unit INEOS ACETYLS UK LIMITED (GB) 2023-10-26 — — US disclosed
US-20230150908-A1 Process for Producing Acetic Acid INEOS ACETYLS UK LIMITED (GB) 2023-05-18 — — US disclosed
US-20230052743-A1 Separation Process and Apparatus INEOS ACETYLS UK LIMITED (GB) 2023-02-16 — — US disclosed
EP-0768295-A1 PROCESS FOR PRODUCING ACETIC ACID DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1997-04-16 — — EP disclosed
EP-0752406-A1 Process for the production of acetic acid by carbonylation BP Chemicals Limited (GB) 1997-01-08 — — EP disclosed
EP-0749948-A1 Process for the carbonylation of alkyl alcohols and/or reactive derivatives thereof BP Chemicals Limited (GB) 1996-12-27 — — EP disclosed
EP-0728727-A1 Process for the carbonylation of an alcohol BP Chemicals Limited (GB) 1996-08-28 — — EP disclosed
EP-0728729-A1 Process for purifying a carboxylic acid BP Chemicals Limited (GB) 1996-08-28 — — EP disclosed
EP-0643034-A1 Process for the production of acetic acid BP Chemicals Limited (GB) 1995-03-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152082-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND HRH1, HRH4, RB1 CYP3A4 1794/4885TSHR 1344/4885MAPK1 416/4885
US-20100152451-A1 OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME ADH1C, ADH1A, ADH5 CYP3A4 277/4885TSHR 1161/4885MAPK1 732/4885
US-20130237708-A1 Optically Active Cyclic Alcohol Compound And Method For Preparing The Same ADH1C, ADH1A, ADH5 CYP3A4 277/4885TSHR 1161/4885MAPK1 732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback